🟢 Painreform is trading 6% up in pre-market with no clear catalyst identified

Painreform is trading 5.77% up now at $1.10 after closing at $1.04 on August 7, 2026, with no clear company-specific catalyst identified for August 10.

• Available search results show no new announcement, earnings release, regulatory decision, or analyst action dated August 10.
• Broader markets are essentially flat, so the advance cannot be confidently attributed to market-wide momentum.
• Older results identify the company’s 2026 name change, but it is not a fresh catalyst.